Several breakthroughs have revolutionized cancer care, including the discovery of oncogenes and tumor suppressor genes, the development of targeted therapies, and the advent of immunotherapy. For instance, drugs like Imatinib have shown remarkable efficacy in treating chronic myeloid leukemia (CML) by targeting specific genetic abnormalities.